Identity of all NHSN facilities is held confidential in accordance with Sections 304, 306, and 308(d) of the Public Health Service Act (42 USC 242b, 242K, and 242m(d)).
METHODS
The NHSN has both a Patient Safety and a Healthcare Personnel Safety surveillance component. Within the Patient Safety component, the data are collected using standardized methods and definitions and are grouped into specific module protocols 4, 5 as follows:
d Device-associated module: See section below. d Procedure-associated module: Facilities choose to monitor in-or outpatients undergoing selected oper ative procedures for the presence of surgical site infection or postprocedure pneumonia. d Medication-associated module: For certain locations, facilities choose to report susceptibility data for selected organisms and/or antimicrobial-use data for selected agents.
The modules may be used singly or simultaneously, but, once selected, they must be used for a minimum of 1 calendar month. All infections are categorized using standard CDC definitions that include laboratory and clinical criteria. 5 Although the Device-associated mod ule may also be used by facilities other than hospitals, including outpatient dialysis centers, this first report focuses only on Device-associated module data re ported by hospitals. A report of data from this module for outpatient dialysis centers will be published sepa rately. Data from the Procedure-associated module will be included in a subsequent NHSN Report when sufficient data are available. Data from the Medica tion-associated module will be published in a separate report.
Device-associated (DA) module: Infection control professionals (ICPs) may choose to collect data on cen tral line-associated primary bloodstream infections, Major: Hospital is an important part of the teaching program of the medical school, and the majority of medical students rotates through multiple clinical services. Graduate: Hospital is used by the medical school for graduate training programs only, ie, residency and/or fellowships. Limited: Hospital is used in the medical school's teaching program only to a limited extent.
ventilator-associated pneumonias, or urinary catheterassociated urinary tract infections (UTIs) that occur in patients staying in a patient care location such as an intensive care unit (ICU), specialty care area, or ward. In the NHSN, these locations are further charac terized according to patient population: adults or chil dren (in Tables, pediatric locations are so noted). In neonatal intensive care unit (NICU) locations (level III or level II/III), ICPs collect data on central line-associ ated and umbilical catheter-associated primary blood stream infections or ventilator-associated pneumonia for each of 5 birth-weight categories (#750 g, 751 1000 g, 1001-1500 g, 1501-2500 g, and .2500 g).
Corresponding location-specific denominator data consisting of patient-days and specific device-days are also collected by ICPs or other trained personnel.
RESULTS
Characteristics of the 211 NHSN hospitals from 40 states and the District of Columbia that contributed data for this report are shown in Table 1 . For the Device-associated module in which data volume was sufficient for this first report, we tabulated deviceassociated infection rates and device utilization (DU) ratios for January through December 2006 (Tables 2-10) . Tables 2 to 4 update and augment previously pub lished device-associated rates and DU ratios by type of non-NICU locations. 1, 2 For inclusion in these Tables, the pooled mean infection rates and DU ratios required data from at least 10 different locations of a given type. For the percentile distributions, data from at least 20 different locations are required. Each of the analyses of Device-associated module data excluded rates or DU ratios for locations that did not report at least 50 device-days or patient-days. Because of this, the number of locations contributing data varies in the Tables.
Three new locations-pediatric medical/surgical ICU, medical ward, and medical/surgical ward-had sufficient data to be included in this report. The num ber of locations that were neurosurgical ICU or medical ward was not adequate to provide distributions of any infection rates and DU ratios. For burn ICU, there were insufficient data for ventilator-associated pneu monia and catheter-associated UTI rate and corre sponding DU ratio distributions. For trauma ICU, insufficient data were available for ventilator-associ ated pneumonia rate distributions and for catheterassociated UTI rate and urinary catheter utilization ratio distributions.
The data for adult combined medical/surgical ICUs were split into 2 groups by type of hospital: ''major teaching'' and ''all others.'' Major teaching status was defined as a hospital that is an important part of the teaching program of a medical school and the majority of medical students rotates through multiple clinical services (see also footnote to Table 1 ).
For the Device-associated module, in non-NICU loca tions, the device-days consisted of the total number of central line-days, urinary catheter-days, and ventilatordays. The DU of a location is one measure of invasive practices in that location and constitutes an extrinsic risk factor for HAI.
2 DU may also serve as a marker for severity of illness of patients, that is, patients' intrin sic susceptibility to infection.
Tables 5 to 10 update and augment the previously published, device-associated rates and DU ratios from 1, 3 New for the NHSN Report are the 2 lowest birth-weight categories and separate Tables for central line-associated bloodstream infections (BSI), umbil ical catheter-associated BSI, and ventilator-associated pneumonia in level III and level II/III NICUs. For NICUs in the Device-associated module, device-days consist of the total number of central line-days, umbilical catheterdays, and ventilator-days. Each of the analyses of NICU data excluded rates or DU ratios for units that did not report at least 50 device-days or patient-days. Because of this, the number of units contributing data varies in the Tables. Although the percentile distribu tion of the rates is provided, for most birth-weight categories the number of ventilator-associated pneu monias and ventilator-days is still small and the data should be considered provisional. Tables 11 to 17 are new for this report and provide data on select attributes of the device-associated infections for each location. For example, Tables 11, 14, and 15 show the frequency and percentage distribution of the specific sites of BSI and the criterion used for identifying these infections. Note that for adult and pediatric ICUs and wards, only laboratory-confirmed BSI are allowed and shown, whereas clinical sepsis is included as a valid BSI specific site for neonates in NICU. For some of the patient care locations in these Tables, the number The hospitals reporting data included in this report are a subset of those that were members of the NNIS system, and the characteristics shown in Table 1 reflect this. However, as more states elect to use the NHSN as their system for meeting mandatory HAI reporting re quirements and as enrollment is opened to all facilities, we expect to have a more diverse group of healthcare facilities reporting in the future.
Comparisons of these data with those of like loca tions from the last NNIS Report may be misleading. As noted in the results, it is not possible to compare the NICU data with the High Risk Nursery data of the NNIS system because of the multiple changes imple mented in NHSN and because the volume of data is still limited for several of the birth-weight categories. An other difference in the NHSN is that data from pediatric ICUs are no longer combined with adult ICU data (eg, in the NNIS, pediatric surgical ICUs were combined with adult surgical ICUs). Data from pediatric ICU types are now reported as their own specialty types; for instance, pediatric medical/surgical ICU is separated and had sufficient data for inclusion in this report. Another ex ample is that, in the NNIS Report, the central lineassociated BSI rate for medical ICU was 5.0, and, in this report, it is 2.9. Two factors may account for this difference: (1) a change in the numerator in 2006 
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Number of ventilator-days Number of ventilator-days y Number of patient-days . such that only central line-associated laboratoryprevention campaigns have been implemented by confirmed BSIs were included, whereas, previously, many hospitals since 2001. [6] [7] [8] clinical sepsis infections were also included, and (2) Tables 11 to 17 were included to aid the reader in inan actual reduction in the number of BSI. This latter terpreting the rates data. For example, most of the cen factor may be particularly likely because BSI tral line-associated and umbilical catheter-associated 
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BSI were identified using the most objective criterion (1a) 5 ; however, for adult and pediatric locations, there was considerable variation. Similarly, the specific site of ventilator-associated pneumonia most frequently reported used the clinical criteria of PNU1 for all loca tions. 5 However, in adult and pediatric locations, nearly 40% of ventilator-associated pneumonias re ported used the more rigorous criteria of PNU2 and PNU3. 5 The specific site of catheter-associated UTI most frequently reported was symptomatic UTI. How ever, the distinction between this type of UTI and asymptomatic bacteriuria is often only the presence 
Number of ventilator-days Number of ventilator-days y Number of patient-days . of fever, 5 which can be difficult to attribute completely to infection versus other processes in critically ill patients.
If you would like to compare your hospital's rates and ratios with those in this report, you must first col lect information from your hospital in accordance with the methods described for the NHSN System. 4, 5 You should also refer to Appendices A and B for further in structions. Appendix A discusses the calculation of in fection rates and DU ratios for the Device-associated module. Appendix B gives a step-by-step method for interpretation of percentiles of infection rates or DU ratios. A high rate or ratio (.90th percentile) does not necessarily define a problem; it only suggests an area for further investigation. Similarly, a low rate or ratio (,10th percentile) may be the result of inadequate in fection detection. Hospitals should use these data to guide local prevention strategies and other quality improvement efforts aimed at reducing infection rates as much as possible. it is, then the rate (ratio) is a high outlier, which may indicate a problem.
Determining whether your hospital's rate or ratio is a LOW outlier
Step 6. If rate or ratio is below the median, deter mine whether the rate (ratio) is below the 25th percen tile. At the 25th percentile, 25% of the hospitals had lower rates (ratios) and 75% of the hospitals had higher rates (ratios).
Step 7. If the rate (ratio) is below the 25th percentile, determine whether it is below the 10th percentile. If the rate is, then it is a low outlier, which may be due to underreporting of infections. If the ratio is below the June 2007 301 10th percentile, it is a low outlier and may be due to in frequent and/or short duration of device use.
Note: Device-associated infection rates and device utilization ratios should be examined together so that preventive measures may be appropriately targeted. For example, you find that the ventilator-associated pneumonia rate for a certain type of ICU is consis tently above the 90th percentile and the ventilator uti lization ratio is routinely between the 75th and 90th percentile. Because the ventilator is a significant risk factor for pneumonia, you may want to target your efforts on reducing the use of ventilators or limiting the duration with which they are used on patients to lower the ventilator-associated pneumonia rate in the unit.
